A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Recruiting now · Phase 1/Phase 2
Conditions studied: Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer, Squamous Non-Small Cell Lung Cancer
In brief
This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents
Key facts
- Study ID
- NCT05123482
- Run by
- AstraZeneca
- People needed
- 460
- Starts
- 2021-10-18
- Expected to finish
- 2027-09-29
- Last updated by the study team
- 2026-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Kunming, China (enrolling)
- Research Site — Budapest, Hungary (enrolling)
- Research Site — Beijing, China (enrolling)
- Research Site — Chongqing, China (enrolling)
- Research Site — Budapest, Hungary (enrolling)
- Research Site — Santa Monica, California, United States (enrolling)
- Research Site — Santa Rosa, California, United States (enrolling)
- Research Site — Albuquerque, New Mexico, United States (enrolling)
- Research Site — Commack, New York, United States (enrolling)
- Research Site — Changsha, China (enrolling)
- Research Site — Shandong, China (enrolling)
- Research Site — Pittsburgh, Pennsylvania, United States (enrolling)
- Research Site — Houston, Texas, United States (enrolling)
- Research Site — Boston, Massachusetts, United States (enrolling)
- Research Site — Melbourne, Australia (enrolling)
- Research Site — St Louis, Missouri, United States (enrolling)
- Research Site — Anderlecht, Belgium (enrolling)
- Research Site — Leuven, Belgium (enrolling)
- Research Site — Calgary, Alberta, Canada (enrolling)
- Research Site — Vancouver, British Columbia, Canada (enrolling)
- Research Site — Ottawa, Ontario, Canada (enrolling)
- Research Site — Toronto, Ontario, Canada (enrolling)
- Research Site — Charlotte, North Carolina, United States (enrolling)
- Research Site — Baltimore, Maryland, United States (enrolling)
- Research Site — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.